WhatsApp
backNews Article

Caplin Point Laboratories Announces ₹241.88 Crores Revenue and ₹130.51 Crores Net Profit for Q2 2026

Company releases unaudited standalone financials including balance sheet and cash flow for half year ended September 30, 2026

Caplin Point Laboratories Limited announced its unaudited standalone financial results for the quarter and half year ended September 30, 2026, reporting revenue from operations of ₹241.88 crores and a net profit of ₹130.51 crores for Q2 2026. The company also released a balance sheet and cash flow statement reflecting robust operational cash flows and investments during the period.

7 days ago|CAPLIPOINT-2.31%
Caplin Point Laboratories LimitedBSE:524742NSE:CAPLIPOINTFinancial Results

Caplin Point Laboratories Limited

Financial Results

Caplin Point Laboratories Limited reported its unaudited standalone financial results for the quarter ended September 30, 2026, with revenue from operations totaling ₹241.88 crores and a net profit of ₹130.51 crores.

The company's total income including other income reached ₹292.92 crores for Q2 2026, compared to ₹234.40 crores in Q2 2025.

Total expenses for the quarter were ₹125.87 crores, covering costs such as materials, traded goods, employee benefits, depreciation, and other expenses.

For the half year ended September 30, 2026, revenue from operations was ₹444.83 crores and net profit reached ₹250.89 crores.

The balance sheet as of September 30, 2026, showed total assets of ₹2,408.83 crores and equity share capital of ₹15.20 crores.

Cash flow statements indicated a net cash inflow from operating activities of ₹103.93 crores during the half year period, with investments and financing activities recorded accordingly.

Highlights

  • Q2 2026 revenue from operations: ₹241.88 crores
  • Q2 2026 net profit: ₹130.51 crores
  • Half year revenue from operations: ₹444.83 crores
  • Half year net profit: ₹250.89 crores
  • Total assets as of September 30, 2026: ₹2,408.83 crores
  • Earnings per share for Q2 2026: ₹17.17 basic

Key Data Snapshot

Quarter EndedSeptember 30, 2026
Revenue from Operations₹241.88 crores
Net Profit₹130.51 crores
Total Income (including Other Income)₹292.92 crores
Earnings Per Share (Basic)₹17.17
Half Year Ended Revenue from Operations₹444.83 crores
Half Year Ended Net Profit₹250.89 crores
Total Assets as of September 30, 2026₹2,408.83 crores

What happened

  • Caplin Point Laboratories approved unaudited standalone financial results for the quarter and half year ended September 30, 2026.
  • The company reported ₹241.88 crores revenue from operations for Q2 2026.
  • Net profit for the quarter was ₹130.51 crores.
  • The Board meeting was held on November 12, 2026, and financial results were reviewed by statutory auditors.

Financial performance

  • Total income including other income for Q2 2026 was ₹292.92 crores.
  • Total expenses for Q2 2026 were ₹125.87 crores, comprising cost of materials, purchase of traded goods, employee expenses, and depreciation.
  • Half year revenue from operations reached ₹444.83 crores with net profit of ₹250.89 crores.
  • Earnings per share (basic) for Q2 2026 stood at ₹17.17.

Operational performance

  • Cash generated from operations during the half year was ₹163.82 crores after adjustments for working capital.
  • Net cash inflow from operating activities was ₹103.93 crores for the half year.
  • Investing activities showed net cash outflow of ₹54.52 crores; financing activities recorded net cash outflow of ₹60.92 crores.
  • Cash and cash equivalents at September 30, 2026 stood at ₹32.83 crores.

Background and context

  • Caplin Point Laboratories is engaged solely in pharmaceutical formulations.
  • Financial results were prepared in accordance with Indian Accounting Standards (Ind AS) as per SEBI Regulations.
  • The company paid dividends amounting to ₹60.81 crores during the half year.
  • The standalone financial statements detail company performance excluding consolidated subsidiaries.

More News on Financial Results

View all

Latest corporate announcements and market updates in Financial Results.

View all news
Caplin Point Laboratories Announces ₹241.88 Crores | Stockk News